Vaidya Sane Ayurved Laboratories Limited has informed the Exchange that Company has entered into Shareholding agreement to acquire Equity shares in with Cure and Care Primary Care Private Limited also known as Raphacure, Details of this arrangement are attached herewith.
General updates
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Undertaking about non applicability of Corporate Governance under Regulation 27 of SEBI (LODR) Regulations, 2015
General updates
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange that NABH Madhavbaug Khopoli Hospital has been granted certification under AYUSH Entry Level Certification (AELC) Programme.
Disclosure of other UPSI/material event
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Company's Hospital is now empaneled with SBI General Insurance Company Limited and it will allow Company to offer cashless services to its patients.
Closure of trading window
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Closure of trading window for quarter ended 30th June 2022
Annual General Meeting
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 29-Jun-2022
Annual General Meeting
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Voting results of Annual General Meeting held on 29-Jun-2022
Annual General Meeting
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Scrutinizer report of Annual General Meeting held on 29-Jun-2022
Annual General Meeting
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Proceedings of Annual General Meeting held on 29-Jun-2022
General updates
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Corrigendum to Annual Report for Financial Year 2021-22 submitted on 06th June 2022.
Book Closure
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 22-Jun-2022 to 29-Jun-2022 for the purpose of Meeting.
Record Date
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange that Record date for the purpose of Meeting is 17-Jun-2022.
General updates
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Annual Report under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Reply to Clarification Sought- Financial Results
MADHAVBAUG : The Exchange had sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed.
Clarification- Financial Results
MADHAVBAUG : The Exchange has sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
-
Newspaper Advertisements
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Financial Results published in Newspaper- Financial Express and Navshakti dated 05th May 2022
General updates
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Statement of Deviation or Variation in usage of funds raised through public issue pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Financial Result Updates
Vaidya Sane Ayurved Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.
Press Release
Vaidya Sane Ayurved Laboratories Limited has submitted the Exchange press release dated 04-May-2022 titled Press Release-March 2022
Outcome of Board Meeting
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Board of Directors in its Meeting held on 04-May-2022 considered and approved financial statements for the period ended March 2022 and Other business matters
Newspaper Advertisements
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Newspaper Advertisements-Media Coverage- Samyojanam 2022- National Ayurveda Youth Conclave
General updates
Vaidya Sane Ayurved Laboratories Limited has submitted Exchange Compliance Certificate under regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
General updates
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2022
General updates
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Non-Applicability of Corporate Governance report under Regulation 27 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
General updates
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Compliance Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
General updates
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018
Disclosure under SEBI Takeover Regulations
Promoter/Promoter Group of Vaidya Sane Ayurved Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Disclosure under SEBI Takeover Regulations
Promoter/Promoter Group of Vaidya Sane Ayurved Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Disclosure under SEBI Takeover Regulations
Promoter/Promoter Group of Vaidya Sane Ayurved Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Closure of trading window
Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Closure of trading window
mibPULSE will help you to stay on top of heart disease.